Woan
Chung-Jin Woan, Santa Clarita, CA US
Patent application number | Description | Published |
---|---|---|
20110238384 | ADVANCING LAYER SURFACE GRID GENERATION - A method of generating a grid on a surface comprises the steps of forming a layer curve along the surface, forming a plurality of points along the layer curve and extending a tangent vector from each one of the most recently formed points. The method may further comprise forming a set of additional points on the surface at a step distance from corresponding ones of the most recently formed points. The set of additional points may be interconnected to form an additional layer curve. The set of additional points may be connected with the corresponding ones of the most recently formed points to form a layer of quadrilateral faces wherein each one of the faces comprises a column. The growth of a column may be terminated upon an aspect ratio of the face in the column exceeding a predetermined value. The steps of extending tangent vectors, forming the set of additional points and forming an additional layer curve may be iteratively repeated until each one of the columns is terminated. | 09-29-2011 |
Karrune V. Woan, Wellington, FL US
Patent application number | Description | Published |
---|---|---|
20080299100 | Topical Co-Enzyme Q10 Formulations and Methods of Use - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 12-04-2008 |
20120164215 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 06-28-2012 |
20120201801 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 08-09-2012 |
Karrune V. Woan, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20130189237 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 07-25-2013 |
20140023627 | TOPICAL CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animcal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 01-23-2014 |
20140255372 | CO-ENZYME Q10 FORMULATIONS AND METHODS OF USE - Topical formulations of CoQ10 reduce the rate of tumor growth in an animal subject. In the experiments described herein, CoQ10 was shown to increase the rate of apoptosis in a culture of skin cancer cells but not normal cells. Moreover, treatment of tumor-bearing animals with a topical formulation of CoQ10 was shown to dramatically reduce the rate of tumor growth in the animals. | 09-11-2014 |
Karrune Veeraprasert Woan, Gainesville, FL US
Patent application number | Description | Published |
---|---|---|
20150056213 | SELECTIVE HISTONE DEACTYLASE 6 INHIBITORS - Disclosed are selective histone deactylase inhibitors (HDACi) that having Formula (I). Methods of making and using these inhibitors for the treatment of cancer, in particular melanoma are also disclosed. | 02-26-2015 |